Author

Jan Rijn Zeevaart

South African Nuclear Energy Corporation (South Africa)ORCID 0000-0003-0794-3012Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

Ana Katrina MapanaoiD· 1 shared Cristina MülleriD· 1 shared Fabienne Flühmann· 1 shared Julia Fricke· 1 shared Kristel KegleriD· 1 shared Nicholas P. van der MeuleniD· 1 shared Peter BernhardtiD· 1 shared Roger SchibliiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Ana Katrina MapanaoORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyEuropean Journal of Nuclear Medicine and Molecular ImagingPeer-reviewedJul 24, 2024

Comparison of the tolerability of 161Tb- and 177Lu-labeled somatostatin analogues in the preclinical setting

Sarah D. Busslinger, Ana Katrina Mapanao, Kristel Kegler…·Cristina Müller

This study compares the tolerability of 161Tb- and 177Lu-labeled somatostatin analogues in mice, finding that SSTR antagonists caused more hematologic changes than agonists, but both were safe at therapeutic activity levels.

27 citationstop 3%

mouseexperimental assay

𝕏 PostBluesky